Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-09 09:13 am Purchase | 13G | IDEAL POWER INC IPWR | HIRSCHMAN ORIN | 700,000 9.5% | 700,000 (New Position) | View |
2024-04-09 08:49 am Purchase | 13G | INTELLICHECK INC IDN | HIRSCHMAN ORIN | 1,598,953 8.2% | 1,598,953 (New Position) | View |
2024-04-09 08:46 am Purchase | 13G | ACASTI PHARMA INC NO PAR ACST | HIRSCHMAN ORIN | 567,812 6% | 567,812 (New Position) | View |
2024-03-25 9:52 pm Sale | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 0 0% | -2,040,540 (Position Closed) | View |
2024-03-20 07:00 am Purchase | 13G | BIOFRONTERA INC BFRI | HIRSCHMAN ORIN | 501,434 9.9% | 501,434 (New Position) | View |
2024-02-21 06:01 am Sale | 13G | BRAINSWAY LTD SPONSORED ADS BWAY | HIRSCHMAN ORIN | 682,482 4.1% | -356,046 (-34.28%) | View |
2024-02-13 06:34 am Purchase | 13G | EVOKE PHARMA INC EVOK | HIRSCHMAN ORIN | 847,000 9.99% | 847,000 (New Position) | View |
2024-02-07 7:16 pm Sale | 13G | BIODESIX INC BDSX | HIRSCHMAN ORIN | 3,408,946 3.8% | -2,159,955 (-38.79%) | View |
2024-02-07 7:01 pm Sale | 13G | COGNITION THERAPEUTICS INC CGTX | HIRSCHMAN ORIN | 1,448,270 4.8% | -589,583 (-28.93%) | View |
2024-02-07 6:58 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | HIRSCHMAN ORIN | 2,662,324 8.7% | 747,104 (+39.01%) | View |
2024-02-07 6:55 pm Purchase | 13G | LIGHTPATH TECHNOLOGIES INC LPTH | HIRSCHMAN ORIN | 3,723,932 9.9% | 144,100 (+4.03%) | View |
2024-02-07 6:55 pm Purchase | 13G | APREA THERAPEUTICS INC APRE | HIRSCHMAN ORIN | 349,300 11% | 4,300 (+1.25%) | View |
2024-02-07 6:55 pm Purchase | 13G | APYX MED CORP COM APYX | HIRSCHMAN ORIN | 2,040,540 5.9% | 156,259 (+8.29%) | View |
2024-02-07 6:55 pm Purchase | 13G | BK TECHNOLOGIES CORP COM BKTI | HIRSCHMAN ORIN | 330,896 9.6% | 330,896 (New Position) | View |
2024-02-07 6:55 pm Purchase | 13G | BRAINSWAY LTD SPONSORED ADS BWAY | HIRSCHMAN ORIN | 1,038,528 6.3% | 33,093 (+3.29%) | View |
2024-02-07 6:55 pm Purchase | 13G | COYA THERAPEUTICS INC COYA | HIRSCHMAN ORIN | 1,164,372 8.1% | 471,977 (+68.17%) | View |
2024-02-07 6:55 pm Purchase | 13G | ELECTROVAYA INC ELVA | HIRSCHMAN ORIN | 3,353,308 9.9% | 3,353,308 (New Position) | View |
2024-02-07 6:55 pm Purchase | 13G | ELUTIA INC ELUT | HIRSCHMAN ORIN | 1,886,556 9.9% | 17,026 (+0.91%) | View |
2024-02-07 6:55 pm Purchase | 13G | KWESST MICRO SYS INC KWE | HIRSCHMAN ORIN | 556,175 9.9% | 156,175 (+39.04%) | View |
2024-02-07 6:55 pm Purchase | 13G | MEDICENNA THERAPEUTICS CORP MDNA | HIRSCHMAN ORIN | 4,672,075 6.7% | 242,092 (+5.46%) | View |